Align Technology (NASDAQ:ALGN) Issues Earnings Results

Align Technology (NASDAQ:ALGN) announced its earnings results on Wednesday. The medical equipment provider reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.31 by $0.04, Briefing.com reports. The business had revenue of $977.87 million during the quarter, compared to analysts’ expectations of $990.05 million. Align Technology had a return on equity of 14.07% and a net margin of 11.34%. The company’s quarterly revenue was up 1.8% on a year-over-year basis. During the same quarter last year, the business posted $1.62 earnings per share. Align Technology updated its Q4 2024 guidance to EPS.

Align Technology Stock Performance

Align Technology stock opened at $216.42 on Friday. The firm’s 50 day moving average price is $234.20 and its two-hundred day moving average price is $250.96. The firm has a market cap of $16.29 billion, a PE ratio of 35.65, a P/E/G ratio of 5.33 and a beta of 1.64. Align Technology has a twelve month low of $176.34 and a twelve month high of $335.40.

Insider Activity

In other news, Director C Raymond Larkin, Jr. acquired 6,500 shares of Align Technology stock in a transaction that occurred on Thursday, August 15th. The stock was purchased at an average price of $235.33 per share, with a total value of $1,529,645.00. Following the completion of the transaction, the director now owns 28,247 shares in the company, valued at approximately $6,647,366.51. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.62% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on ALGN shares. Evercore ISI lowered their price objective on shares of Align Technology from $270.00 to $250.00 and set an “outperform” rating on the stock in a research note on Thursday. Piper Sandler dropped their price target on Align Technology from $285.00 to $275.00 and set an “overweight” rating on the stock in a report on Thursday. Robert W. Baird cut their price objective on Align Technology from $325.00 to $276.00 and set an “outperform” rating for the company in a research report on Thursday. StockNews.com upgraded Align Technology from a “hold” rating to a “buy” rating in a research report on Thursday, September 19th. Finally, Needham & Company LLC restated a “hold” rating on shares of Align Technology in a report on Thursday. One analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $276.38.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.